Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Protalix BioTherapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q3 2024
- Shares held
- 4.40M
- +960.2K (+28.0%) vs. Q3 2024
- Total value
- $8.40M
- +$4.87M (+138.0%) vs. Q3 2024
- New holders
- 8
- 12 more added
- Sold out
- 7
- 8 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $30.9M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $11.9M |
| Q4 2023 | 66 | $17.6M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.45M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.24M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SRS Capital Advisors, Inc. | 39 | $74 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $376 | 0.00% | 00.0% | Unchanged |
| Y.D. More Investments Ltd | 220 | $414 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 250 | $470 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 300 | $564 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 632 | $1.19K | 0.00% | +632 | New |
| Group One Trading, L.P. | 656 | $1.23K | 0.00% | +656 | New |
| BNP Paribas Arbitrage, SA | 716 | $1.35K | 0.00% | +716 | New |
| Point72 (DIFC) Ltd | 901 | $1.69K | 0.00% | −10,699−92.2% | Reduced |
| Lazard Asset Management LLC | 1,255 | $2.00K | 0.00% | +1,255 | New |
| JPMorgan Chase & Co | 1,595 | $3.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 2,458 | $4.62K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6,000 | $11.1K | 0.00% | 00.0% | Unchanged |
| Harbour Investment Management LLC | 10,100 | $19.0K | 0.01% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 10,200 | $19.2K | 0.00% | 00.0% | Unchanged |
| Altshuler Shaham Ltd | 12,142 | $22.8K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 14,000 | $26.3K | 0.00% | −2,000−12.5% | Reduced |
| Lido Advisors, LLC | 15,554 | $29.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 18,178 | $34.2K | 0.00% | +17,886+6,125.3% | Added |
| Y-Intercept (Hong Kong) Ltd | 18,818 | $35.4K | 0.00% | +18,818 | New |
| PFG Investments, LLC | 20,730 | $39.0K | 0.00% | +20,730 | New |
| Aptus Capital Advisors, LLC | 23,363 | $43.9K | 0.00% | +1,026+4.6% | Added |
| Qube Research & Technologies Ltd | 24,867 | $46.8K | 0.00% | −11,571−31.8% | Reduced |
| Capital Performance Advisors LLP | 25,976 | $48.8K | 0.02% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 29,307 | $55.1K | 0.00% | +5,686+24.1% | Added |
| Bank of America Corp | 33,714 | $63.4K | 0.00% | −11,280−25.1% | Reduced |
| Virtu Financial LLC | 34,276 | $64.0K | 0.00% | −9,112−21.0% | Reduced |
| Barclays PLC | 34,323 | $64.5K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 36,400 | $68.4K | 0.00% | +36,400 | New |
| HSBC Holdings PLC | 40,023 | $75.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 49,710 | $93.5K | 0.00% | −531−1.1% | Reduced |
| Commonwealth Equity Services, LLC | 50,000 | $94.0K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 53,507 | $100.6K | 0.03% | +6,434+13.7% | Added |
| Orin Green Financial, LLC | – | $135.4K | 0.06% | – | – |
| Squarepoint Ops LLC | 73,940 | $139.0K | 0.00% | +18,522+33.4% | Added |
| Marshall Wace, LLP | 101,899 | $191.6K | 0.00% | +101,899 | New |
| Jane Street Group, LLC | 113,616 | $213.6K | 0.00% | +67,664+147.2% | Added |
| Citadel Advisors LLC | 145,787 | $274.1K | 0.00% | +54,129+59.1% | Added |
| Morgan Stanley | 170,216 | $320.0K | 0.00% | +127,158+295.3% | Added |
| Bridgeway Capital Management, LLC | 181,400 | $341.0K | 0.01% | −2,390−1.3% | Reduced |
| BlackRock, Inc. | 224,657 | $422.4K | 0.00% | +45,873+25.7% | Added |
| Stratos Wealth Partners, LTD. | 270,000 | $507.6K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 305,749 | $575.0K | 0.04% | −129,464−29.7% | Reduced |
| Millennium Management LLC | 387,921 | $729.3K | 0.00% | +14,164+3.8% | Added |
| Northern Trust Corp | 731,742 | $1.38M | 0.00% | +679,451+1,299.4% | Added |
| Renaissance Technologies LLC | 1,118,000 | $2.10M | 0.00% | +162,100+17.0% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −70,817−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −37,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −35,058−100.0% | Sold out |
| Finivi Inc. | 0 | $0 | 0.00% | −14,544−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,055−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,414−100.0% | Sold out |